CNS Pharmaceuticals Achieves Completion of Planned Enrollmen

CNS Pharmaceuticals Achieves Completion of Planned Enrollment in Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

CNS Pharmaceuticals Achieves Completion of Planned Enrollment in Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Houston , Texas , United States , France , Spain , Switzerland , Italy , Jenene Thomas , John Climaco , Company On Twitter , Pharmaceuticals Fast Track Designation For Berubicin , Reata Pharmaceuticals Inc , Nasdaq , Linkedin , Securities Exchange , University Of Texas Md Anderson Cancer Center , Exchange Commission , Facebook , Pharmaceuticals Inc , Overall Survival , Data Safety Monitoring Board , Fast Track Designation , Orphan Drug Designation , New Drug Application , Reata Pharmaceuticals , Waldemar Priebe , Medicinal Chemistry , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act ,